Status:

COMPLETED

A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State

Lead Sponsor:

AbbVie

Conditions:

Systemic Lupus Erythematosus (SLE)

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will evaluate how well elsubrutinib and upadacitinib given alone or ...

Eligibility Criteria

Inclusion

  • Completed Study M19-130 (i.e., the randomized controlled trial of elsubrutinib, upadacitinib, and ABBV-599 \[elsubrutinib/upadacitinib\] combination or matching placebo) and will not have developed any laboratory or clinical discontinuation criteria as defined in that study.
  • On stable background treatment for SLE throughout the study.

Exclusion

  • Active, chronic, or recurrent viral, or bacterial infection.
  • Active tuberculosis (TB)
  • History of gastrointestinal (GI) perforation, diverticulitis, or a significantly increased risk for GI perforation per investigator assessment.
  • Participant require vaccination with live vaccine during study participation.

Key Trial Info

Start Date :

July 27 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 3 2024

Estimated Enrollment :

185 Patients enrolled

Trial Details

Trial ID

NCT04451772

Start Date

July 27 2020

End Date

January 3 2024

Last Update

January 14 2025

Active Locations (87)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 22 (87 locations)

1

Duplicate_AZ Arthritis and Rheumotology Research, PLLC /ID# 227833

Phoenix, Arizona, United States, 85032-9306

2

Wallace Rheumatic Studies Center, LLC /ID# 224374

Beverly Hills, California, United States, 90211

3

Valerius Medical Group & Research Center /ID# 223922

Los Alamitos, California, United States, 90720-5402

4

East Bay Rheumatology Medical /ID# 225493

San Leandro, California, United States, 94578